58 related articles for article (PubMed ID: 14764797)
1. The Polycystic Ovary Morphology-Polycystic Ovary Syndrome Spectrum.
Rosenfield RL
J Pediatr Adolesc Gynecol; 2015 Dec; 28(6):412-9. PubMed ID: 25840648
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity.
Legro RS; Bentley-Lewis R; Driscoll D; Wang SC; Dunaif A
J Clin Endocrinol Metab; 2002 May; 87(5):2128-33. PubMed ID: 11994352
[TBL] [Abstract][Full Text] [Related]
3. Alterations in Glucose Effectiveness and Insulin Dynamics: Polycystic Ovary Syndrome or Body Mass Index.
Vuguin P; Sopher AB; Roumimper H; Chin V; Silfen M; McMahon DJ; Fennoy I; Oberfield SE
Horm Res Paediatr; 2017; 87(6):359-367. PubMed ID: 28478437
[TBL] [Abstract][Full Text] [Related]
4. Evidence that obesity and androgens have independent and opposing effects on gonadotropin production from puberty to maturity.
Rosenfield RL; Bordini B
Brain Res; 2010 Dec; 1364():186-97. PubMed ID: 20816944
[TBL] [Abstract][Full Text] [Related]
5. Association of the -243 A-->G polymorphism of the glutamate decarboxylase 2 gene with obesity in girls with premature pubarche.
Witchel SF; White C; Libman I
Fertil Steril; 2009 May; 91(5):1869-76. PubMed ID: 18371956
[TBL] [Abstract][Full Text] [Related]
6. Clinical Phenotypes of PCOS: a Cross-Sectional Study.
Elsayed AM; Al-Kaabi LS; Al-Abdulla NM; Al-Kuwari MS; Al-Mulla AA; Al-Shamari RS; Alhusban AK; AlNajjar AA; Doi SAR
Reprod Sci; 2023 Nov; 30(11):3261-3272. PubMed ID: 37217826
[TBL] [Abstract][Full Text] [Related]
7. Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome.
Ding H; Zhang J; Zhang F; Zhang S; Chen X; Liang W; Xie Q
Front Endocrinol (Lausanne); 2021; 12():741764. PubMed ID: 34745009
[TBL] [Abstract][Full Text] [Related]
8. The role of polymorphism in various potential genes on polycystic ovary syndrome susceptibility and pathogenesis.
Chaudhary H; Patel J; Jain NK; Joshi R
J Ovarian Res; 2021 Sep; 14(1):125. PubMed ID: 34563259
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiological mechanisms of gonadotropins- and steroid hormones-related genes in etiology of polycystic ovary syndrome.
Shaaban Z; Khoradmehr A; Jafarzadeh Shirazi MR; Tamadon A
Iran J Basic Med Sci; 2019 Jan; 22(1):3-16. PubMed ID: 30944702
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive genotyping of Turkish women with hirsutism.
Polat S; Karaburgu S; Ünlühizarcı K; Dündar M; Özkul Y; Arslan YK; Karaca Z; Kelestimur F
J Endocrinol Invest; 2019 Sep; 42(9):1077-1087. PubMed ID: 30811025
[TBL] [Abstract][Full Text] [Related]
11. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.
Rosenfield RL; Ehrmann DA
Endocr Rev; 2016 Oct; 37(5):467-520. PubMed ID: 27459230
[TBL] [Abstract][Full Text] [Related]
12. Evidence for gonadotrophin secretory and steroidogenic abnormalities in brothers of women with polycystic ovary syndrome.
Liu DM; Torchen LC; Sung Y; Paparodis R; Legro RS; Grebe SK; Singh RJ; Taylor RL; Dunaif A
Hum Reprod; 2014 Dec; 29(12):2764-72. PubMed ID: 25336708
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of diseases of steroid hormone production, metabolism and action.
Honour JW
J Clin Res Pediatr Endocrinol; 2009; 1(5):209-26. PubMed ID: 21274298
[TBL] [Abstract][Full Text] [Related]
14. The adrenal and polycystic ovary syndrome.
Yildiz BO; Azziz R
Rev Endocr Metab Disord; 2007 Dec; 8(4):331-42. PubMed ID: 17932770
[TBL] [Abstract][Full Text] [Related]
15. The hormonal phenotype of Nonclassic 3 beta-hydroxysteroid dehydrogenase (HSD3B) deficiency in hyperandrogenic females is associated with insulin-resistant polycystic ovary syndrome and is not a variant of inherited HSD3B2 deficiency.
Carbunaru G; Prasad P; Scoccia B; Shea P; Hopwood N; Ziai F; Chang YT; Myers SE; Mason JI; Pang S
J Clin Endocrinol Metab; 2004 Feb; 89(2):783-94. PubMed ID: 14764797
[TBL] [Abstract][Full Text] [Related]
16. 17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome.
Pasquali R; Patton L; Pocognoli P; Cognigni GE; Gambineri A
J Clin Endocrinol Metab; 2007 Nov; 92(11):4208-17. PubMed ID: 17785360
[TBL] [Abstract][Full Text] [Related]
17. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome.
Legro RS; Finegood D; Dunaif A
J Clin Endocrinol Metab; 1998 Aug; 83(8):2694-8. PubMed ID: 9709933
[TBL] [Abstract][Full Text] [Related]
18. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
Yildiz BO; Yarali H; Oguz H; Bayraktar M
J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
